These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 2495352)
1. Effects of ethmozin on excitability in sheep Purkinje fibers: the balance among active and passive cellular properties which comprise the electrophysiologic matrix. Arnsdorf MF; Sawicki GJ J Pharmacol Exp Ther; 1989 Mar; 248(3):1158-66. PubMed ID: 2495352 [TBL] [Abstract][Full Text] [Related]
2. Effects of encainide on the determinants of cardiac excitability in sheep Purkinje fibers. Arnsdorf MF; Schmidt GA; Sawicki GJ J Pharmacol Exp Ther; 1985 Jan; 232(1):40-8. PubMed ID: 3917508 [TBL] [Abstract][Full Text] [Related]
3. Electrophysiologic actions and interactions between lysophosphatidylcholine and lidocaine in the nonsteady state: the match between multiphasic arrhythmogenic mechanisms and multiple drug effects in cardiac Purkinje fibers. Sawicki GJ; Arnsdorf MF J Pharmacol Exp Ther; 1985 Dec; 235(3):829-38. PubMed ID: 4078734 [TBL] [Abstract][Full Text] [Related]
4. Effects of quinidine sulfate on the balance among active and passive cellular properties that comprise the electrophysiologic matrix and determine excitability in sheep Purkinje fibers. Arnsdorf MF; Sawicki GJ Circ Res; 1987 Aug; 61(2):244-55. PubMed ID: 3621490 [TBL] [Abstract][Full Text] [Related]
5. The effect of lidocaine on components of excitability in long mammalian cardiac Purkinje fibers. Arnsdorf MF; Bigger JT J Pharmacol Exp Ther; 1975 Nov; 195(2):206-15. PubMed ID: 1185592 [TBL] [Abstract][Full Text] [Related]
6. Antiarrhythmic effects of ethmozin in cardiac Purkinje fibers: suppression of automaticity and abolition of triggering. Dangman KH; Hoffman BF J Pharmacol Exp Ther; 1983 Dec; 227(3):578-86. PubMed ID: 6317840 [TBL] [Abstract][Full Text] [Related]
7. Flecainide and the electrophysiologic matrix: the effects of flecainide acetate on the determinants of cardiac excitability in sheep Purkinje fibers. Arnsdorf MF; Sawicki GJ J Cardiovasc Electrophysiol; 1996 Dec; 7(12):1172-82. PubMed ID: 8985806 [TBL] [Abstract][Full Text] [Related]
8. The electrophysiologic effects of tolamolol (UK-6558-01) on the passive membrane properties of mammalian cardiac Purkinje fibers. Arnsdorf MF; Friedlander I J Pharmacol Exp Ther; 1976 Dec; 199(3):601-10. PubMed ID: 1036501 [TBL] [Abstract][Full Text] [Related]
9. State dependence of ethacizin and ethmozin block of sodium current in voltage clamped and internally perfused cardiac Purkinje cells. Makielski JC; Nesterenko VV; Nelson WL; Undrovinas AI; Starmer CF; Rosenshtraukh LV J Pharmacol Exp Ther; 1990 Jun; 253(3):1110-7. PubMed ID: 2162945 [TBL] [Abstract][Full Text] [Related]
10. Membrane action of ethmozin on normoxic and hypoxic canine Purkinje fibers. Tsuji Y; Nishimura M; Osada M; Watanabe Y J Cardiovasc Pharmacol; 1983; 5(6):961-7. PubMed ID: 6196568 [TBL] [Abstract][Full Text] [Related]
11. Observations on the effects of selected antiarrhythmic drugs on mammalian cardiac purkinje fibers with two levels of steady-state potential: influences of lidocaine, phenytoin, propranolol, disopyramide and procainamide on repolarization, action potential shape and conduction. Arnsdorf MF; Mehlman DJ J Pharmacol Exp Ther; 1978 Dec; 207(3):983-91. PubMed ID: 731444 [No Abstract] [Full Text] [Related]
12. [Effect of ethmozin on the electrophysiologic parameters of Purkinje cells in the sheep heart. The frequency-dependent blockade of sodium channels]. Undrovinas AI; Sawicki GJ; Nesterenko VV; Rosenshtraukh LV; Arnsdorf MF Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1986; 9(2):8-15. PubMed ID: 2432909 [TBL] [Abstract][Full Text] [Related]
13. Electrophysiological effects of the new antiarrhythmic drug 3-(diisopropylaminoethylamino)-2',6'-dimethylpropionanilide++ + on dog cardiac muscle. Sato Y; Iijima T; Taira N Arzneimittelforschung; 1989 Jan; 39(1):56-9. PubMed ID: 2719743 [TBL] [Abstract][Full Text] [Related]
14. Effects of imipramine on cellular electrophysiological properties of cardiac Purkinje fibers. Rawling DA; Fozzard HA J Pharmacol Exp Ther; 1979 Jun; 209(3):371-5. PubMed ID: 439013 [TBL] [Abstract][Full Text] [Related]
15. Frequency-dependent effects of antiarrhythmic drugs on action potential duration and refractoriness of canine cardiac Purkinje fibers. Nattel S; Zeng FD J Pharmacol Exp Ther; 1984 Apr; 229(1):283-91. PubMed ID: 6707943 [TBL] [Abstract][Full Text] [Related]
16. Effects of procaine amide, quinidine and ethmozin on delayed afterdepolarizations. Hewett K; Gessman L; Rosen MR Eur J Pharmacol; 1983 Dec; 96(1-2):21-8. PubMed ID: 6363102 [TBL] [Abstract][Full Text] [Related]
17. Electrophysiological effects of ACC-9358, a novel class I antiarrhythmic agent, on isolated canine Purkinje fibers and ventricular muscle. Brown BS J Pharmacol Exp Ther; 1989 Feb; 248(2):552-8. PubMed ID: 2918472 [TBL] [Abstract][Full Text] [Related]
18. The effect of antiarrhythmic drugs on triggered sustained rhythmic activity in cardiac Purkinje fibers. Arnsdorf MF J Pharmacol Exp Ther; 1977 Jun; 201(3):689-700. PubMed ID: 577217 [No Abstract] [Full Text] [Related]
19. Time course of the electrophysiological effects of quinidine on canine cardiac Purkinje fibers: concentration dependence and comparison with lidocaine and disopyramide. Nattel S; Bailey JC J Pharmacol Exp Ther; 1983 Apr; 225(1):176-80. PubMed ID: 6834270 [TBL] [Abstract][Full Text] [Related]
20. Relationship between use-dependent effects of antiarrhythmic drugs on conduction and Vmax in canine cardiac Purkinje fibers. Nattel S J Pharmacol Exp Ther; 1987 Apr; 241(1):282-8. PubMed ID: 3572790 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]